Domestic Delivery For Europe,US,Canada,Australia!
Please note: AASraw does not authorize any resellers.


Rating: Categories: ,

Other names: LY-3437943

AASraw is the professional manufacturer of peptide Retatrutide which has independent lab and large factory as support,all production will be carried out under CGMP regulation and trackable quality control system.AASraw can accept the customized service according to specific requests on peptide raw powder or finished peptide vials.

Quick Quote For Small Order

If you need to purchase this product in vial,please click the following channel to get finished peptide vial(mg/vial) price.👇

Bulk Order Quotation

Product Description

What is Retatrutide?

Retatrutide, a new medication, shows enormous potential for treating diabetes and obesity. The FDA is about to approve this medicine, also known as GGG Tri-agonist, GLP-1/GIP/glucagon tri-agonist, or LY3437943. It is equivalent to other weight-loss medicines such as tirzepatide and semaglutide, although being more effective. When taken in conjunction with a nutritious diet, consistent exercise, and lifestyle adjustments (high blood pressure),retatrutide can cure obesity-related comorbidities such as diabetes or hypertension.

Retatrutide looks to be more successful than other existing weight reduction medications. It achieves its therapeutic benefits through three major mechanisms:

GIPR Agonism: Retatrutide suppresses appetite and reduces fat buildup by functioning as a GIP receptor agonist.This results in less calorie intake and more energy expenditure.

Retatrutide operates as a glucagon-like peptide 1 receptor agonist. This action promotes increased insulin release from the pancreas while decreasing the production of glucagon, a hormone that raises blood sugar levels.

GR Agonism: By acting as a glucagon receptor agonist,retatrutide reduces the release of glucagon. This results in improved blood sugar levels, decreased food intake, and increased energy expenditure, ultimately leading to weight loss.

These combined processes make retatrutide an effective weight reduction medicine that may also benefit comorbidities linked with obesity such as diabetes or hypertension.

How does Retatrutide work?

The promising results of retatrutide, a potential game changer in the public health space, stem from its calculating interaction with the hormones that regulate our appetite.

Retatrutide performs a balancing act by mimicking several hormones. Like Wegovy it mimics GLP-1, a hormone that aids in blood sugar control by triggering insulin secretion post-meal. But it doesn’t stop there.

Retatrutide also mimics tirzepatide in order to simulate GIP, a second hormone linked to insulin secretion. What distinguishes retatrutide is its stimulation of a third hormone, the glucagon receptor, which is found primarily in the liver. This additional boost could be the key to some of the drug’s profound benefits that go far beyond weight loss.

The drug’s preliminary data is making headlines because of its other potential benefits. Retatrutide treatment resulted in a 20 per ident reduction in LDL, or “bad” cholesterol, which is twice the improvement seen with other GLP-1 drugs

The benefits of Retatrutide

①Promote Weight Loss

Retatrutide is more successful than other weight reduction drugs due to its unique mix of mechanisms of action. Because it is a GIPR agonist, it enhances appetite control and prevents fat accumulation. It lowers blood sugar levels by increasing pancreatic insulin release while reducing glucagon release as a GLP-1 agonist. As a GR agonist, it enhances insulin secretion while decreasing glucagon release. These systems aid in weight loss by decreasing calorie intake and raising energy expenditure.

②Improve Blood Sugar Levels

Retatrutide lowers blood sugar levels by modulating glucagon and insulin hormones. Glucagon boosts blood sugar levels while insulin decreases them to establish homeostasis or balance. Because it is a GLP-1 and GR agonist, it enhances pancreatic insulin release while lowering glucagon release. As a result, normal blood sugar levels are achieved.

③Improve Blood Pressure

Retatrutide can help to lose weight and decrease blood pressure. It can help to lose weight by decreasing calorie intake while increasing your energy expenditure. There is evidence that losing weight can help reduce blood pressure. This shows that retatrutide may be beneficial to hypertensive patients.

Side effects of Retatrutide

The side effects of retatrutide are extremely rare. There have been cases where a patient taking retatrutide experienced one of the side effects listed below while taking the medication. These adverse reactions weren’t definitively linked to the therapy; they might have been coincidental and unrelated to the use of retatrutide. Despite this, it was listed as a possible side effect even though the potential side effects are extremely rare.

These are some of the potential retatrutide side effects:

  • Chest pain
  • Depression
  • Difficulty breathing
  • Dizziness
  • Dry mouth
  • Fatigue
  • Headache
  • Irregular heartbeat
  • Swelling in the hands and feet

Retatrutide vs other peptides

Retatrutide VS Semaglutide

Semaglutide and Retatrutide are two different medications used to treat type 2 diabetes. They both work by reducing blood sugar levels but have different methodologies for doing so. Semaglutide (also known as Wegovy and Ozempic ) is an injectable GLP-1 receptor agonist that helps cells in the body secrete more insulin, leading to lowered blood glucose levels when needed.
Retatrutide, on the other hand, is a glucagon-like peptide-1 (GLP-1) analog that works to stimulate beta cells in the pancreas causing insulin release and pancreatic polypeptide release, both of which lower blood glucose levels.

Retatrutide VS Tirzepatide

Retatrutide and Tirzepatide are two anti-obesity weight loss injections that have recently emerged in the health and lifestyle world. Retatrutide is a drug derived from glucagon-like peptide 1 receptor, which helps people reduce their calorie intake by slowing down digestion and boosting feelings of fullness, while Tirzepatide is a dual GLP-1/glucose dependent insulinotropic receptor agonist designed to reduce hunger cravings.

Retatrutide VS Liraglutide

Retatrutide (also known as MK-8349) and liraglutide (also known as Victoza) are artificial hormones that are injected under the skin on a daily basis for the treatment of Type 2 diabetes. While both medications have similar indications, there is evidence that Retatrutide may offer superior blood sugar control compared to liraglutide.

While both are designed to help individuals lose weight, they work in different ways. Retatrutide exhibits appetite-suppressing qualities while Tirzepatide provides blood sugar balance, helping users to control their hunger levels. Therefore, it’s important for someone looking to use either injection to find out which one will best suit their individual needs in order to receive the most benefit from it.

Where to buy Retatrutide?

Retatrutide peptide therapy has a significant impact on overall health. It helps in promoting weight loss, improving blood sugar levels, improving blood pressure, and so much more. Here at AASraw, we’re dedicated to supplying multiple peptides including weight loss, sex health treatments, and other hormones. If you’re interested in wholesale Retatrutide or any other peptides, fill in the format below to schedule your consultation and our customer service representative will contact you. We can’t wait to hear from you!

How to buy Retatrutide from AASraw?

❶To contact us by our email inquiry system, or leave your WhatsApp number to us, our customer service representative(CSR) will contact with you in 12 hours.

❷To provide us with your inquired quantity and address.

❸Our CSR will provide you with the quotation, payment term, tracking number, delivery ways, and estimated arrival date(ETA).

❹Payment done and the goods will be sent out in 12 hours.

❺Goods received and give comments.

Author of this article:
Dr. Monique Hong graduated from UK Imperial College London Faculty of Medicine

Scientific Journal paper Author:
1.Julio Rosenstock MD
Velocity Clinical Research at Medical City,Dallas,TX,USA
2.Thinzar Min
Swansea Bay University Health Board and Swansea University Medical School,Swansea SA2 8PP,UK
3.Clifford J.Bailey
Life and Health Sciences,Aston University,Birmingham B4 7ET,UK
In no way does this doctor/scientist endorse or advocate the purchase, sale, or use of this product for any reason. Aasraw has no affiliation or relationship, implied or otherwise, with this physician. The purpose of citing this doctor is to acknowledge, acknowledge and commend the exhaustive research and development work done by the scientists working on this substance.


[1]Coskun T,Urva S,Roell WC,Qu H,Loghin C,Moyers JS,et al.(September 2022).”LY3437943,a novel triple glucagon,GIP,and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept”.Cell Metabolism.34 (9):1234–1247.e9.doi:10.1016/j.cmet.2022.07.013.PMID 35985340.S2CID 251675508
[2]Lilly’s phase 2 retatrutide results published in The New England Journal of Medicine show the investigational molecule achieved up to 17.5% mean weight reduction at 24 weeks in adults with obesity and overweight”.EliLilly.26 June 2023.Retrieved 3 July 2023.
[3]”Eli Lilly experimental obesity drug could beat rivals in total weight loss for patients”.CNBC.26 June 2023.Retrieved 3 July 2023.
[4]Jastreboff AM,Kaplan LM,Frías JP,Wu Q,Du Y,Gurbuz S,et al.(June 2023).”Triple-Hormone-Receptor Agonist Retatrutide for Obesity – A Phase 2 Trial”.The New England Journal of  Medicine.doi: 10.1056/NEJMoa2301972.PMID 37366315.

Get a Bulk quotation